Osler is a medical diagnostic company that has developed the Osler Origin – a portable diagnostic capable of performing a wide range of testing, with high-performance, in a rapid, low-cost, and easy-to-use manner. The Osler Origin will offer a wide portfolio of diagnostic tests and serve all major healthcare settings, globally.
The round included investment from a strategic investor, M&G Investments, and existing investors, including Oxford Science Enterprises, Braavos Investment Advisers, and Lansdowne Partners.
This investment will support Osler in advancing its Osler Origin product through regulatory activities, and towards market launch.
The Latham team was led by London corporate partner Robbie McLaren, with associates Aaron Bassett, Daria Les, Samantha Si, and Noreen Hesse.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
